Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. iShares U.S. Pharmaceuticals ETF (IHE) is part of the US Health Care segment. BMED's top 3 sector exposures are Health Care and Consumer Discretionary. In contrast, IHE's top sector exposures are Health Care BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.38% for IHE. BMED is down -5.49% year-to-date (YTD) with +$4M in YTD flows. IHE performs better with 2.1% YTD performance, and +$129M in YTD flows. Run a side-by-side ETF comparison of BMED and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BMED IHE | -6.03%-4.25% | -5.68%+1.32% | -5.49%+2.10% | +16.79%+27.98% | +27.36%+59.87% | -1.83%+56.57% |
| Flows | BMED IHE | +$1M+$5M | +$4M+$142M | +$4M+$129M | +$7M+$248M | +$4M+$359M | +$5M+$393M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BMED IHE | +15.26%+16.09% | +17.92%+20.46% | +15.51%+15.96% | +17.58%+15.82% |
| Max drawdown | BMED IHE | -10.40%-5.75% | -14.01%-14.18% | -19.76%-16.04% | -33.96%-16.12% |
| Max drawdown duration | BMED IHE | 50d12d | 113d150d | 237d210d | 1586d669d |
BMED | IHE | |
Last sale 3/13/2026 at 1:30 PM | $28.63 | $86.56 |
| Previous close 03/12/2026 | $28.78 | $86.66 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BMED | IHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BMED | IHE | |
|---|---|---|
| Last price | $28.63 | $86.56 |
| 1D performance | -0.52% | -0.12% |
| AuM | $10.31 M | $995.33 M |
| E/R | 0.77% | 0.38% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
